Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MAHESH G CHANGLANI

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1861499808
CMS profile
758296
Location
MCALLEN, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$10,041.34

8 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

By paying entity

PY2020 · entire year · sorted by reported total

Paying entityAmountRecords
Janssen Pharmaceuticals, Inc $10,041.34 8

Page 1 of 1; records 1–8 of 8 matching records. This page contains 8 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MAHESH G CHANGLANI

NPI 1861499808 · CMS profile ID 758296

Allopathic & Osteopathic Physicians / Internal Medicine / Cardiovascular Disease

MCALLEN, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–8 of 8 matching records. This page contains 8 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1861499808?year=2020&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MAHESH G CHANGLANI, NPI 1861499808, CMS profile ID 758296. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–8 of 8 matching records. This page contains 8 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1861499808?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). MAHESH G CHANGLANI, NPI 1861499808, CMS profile ID 758296. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–8 of 8 matching records. This page contains 8 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1861499808?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
MAHESH G CHANGLANI, NPI 1861499808, CMS profile ID 758296, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–8 of 8 matching records. This page contains 8 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1861499808?year=2020&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

8 matching records · $10,041.34 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 8 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–8 of 8.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Janssen Pharmaceuticals, Inc $1,000.0009/28/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719275467 CMS
Janssen Pharmaceuticals, Inc $300.0004/16/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719275465 CMS
Janssen Pharmaceuticals, Inc $2,000.0003/17/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719275461 CMS
Janssen Pharmaceuticals, Inc $3,300.0002/26/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719275459 CMS
Janssen Pharmaceuticals, Inc $96.1902/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719275455 CMS
Janssen Pharmaceuticals, Inc $15.6702/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719275453 CMS
Janssen Pharmaceuticals, Inc $3,300.0002/12/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719275457 CMS
Janssen Pharmaceuticals, Inc $29.4802/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719275463 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $43,311.20 29
PY2020 $10,041.34 8
PY2021 $11,008.34 15
PY2022 $20,463.53 20
PY2023 $10,462.00 10
PY2025 $137.01 2

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $64,544.59 2
PY2024 Principal investigator $177,608.28 2
PY2023 Principal investigator $10,722.50 2
PY2022 Principal investigator $67,664.80 1
PY2021 Principal investigator $23,910.98 97
PY2020 Principal investigator $47,616.25 4
PY2019 Principal investigator $15,843.75 2

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

97 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novartis Pharmaceuticals Corporation $21,576.00 12/22/2021 Covered Recipient Teaching Hospital
DOCTORS HOSPITAL AT RENAISSANCE
AN OPEN-LABEL EXTENSION TRIAL OF THE PHASE III LIPID-LOWERING TRIALS TO ASSESS THE EFFECT OF LONG TERM DOSING OF INCLISIRAN GIVEN AS SUBCUTANEOUS INJECTIONS IN SUBJECTS WITH HIGH CARDIOVASCULAR RISK AND ELEVATED LDL-C No dispute reported 06/30/2026 965470025
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811787915
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811787917
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811787919
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811787921
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811787923
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811787925
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811787927
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811787929
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811787931
Principal investigator 1 Novo Nordisk AS $11.20 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811787933
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811788011
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811788013
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811788015
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811788017
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811788019
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811788021
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811788023
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811788025
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811788027
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811788029
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811788031
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811788033
Principal investigator 1 Novo Nordisk AS $4.99 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811788035
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811813059
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811813061
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811813063
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811813065
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811813067
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811813069
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811813071
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811813073
Principal investigator 1 Novo Nordisk AS $1.00 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811813075
Principal investigator 1 Novo Nordisk AS $9.99 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811813077
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811813079
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811813081
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811813083
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811813085
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811813087
Principal investigator 1 Novo Nordisk AS $4.99 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811813089
Principal investigator 1 Novo Nordisk AS $4.16 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811813091
Principal investigator 1 Novo Nordisk AS $7.91 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811813093
Principal investigator 1 Novo Nordisk AS $11.20 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811813095
Principal investigator 1 Novo Nordisk AS $14.95 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811813097
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811813099
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811813101
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811813103
Principal investigator 1 Novo Nordisk AS $4.99 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811813105
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811900271
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811900273
Principal investigator 1 Novo Nordisk AS $9.99 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811900275
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811900277
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811900279
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811900281
Principal investigator 1 Novo Nordisk AS $4.16 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811900283
Principal investigator 1 Novo Nordisk AS $7.91 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811900285
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811900287
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811900289
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811900291
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811900293
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811900295
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811900297
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811900299
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811900301
Principal investigator 1 Novo Nordisk AS $4.99 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811900303
Principal investigator 1 Novo Nordisk AS $350.00 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811900305
Principal investigator 1 Novo Nordisk AS $1.00 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811900307
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811900309
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811900311
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811900313
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811900315
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811900317
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811900319
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811911867
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811911869
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811911871
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811911873
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811911875
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811911877
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811911879
Principal investigator 1 Novo Nordisk AS $350.00 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811911881
Principal investigator 1 Novo Nordisk AS $650.00 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811911883
Principal investigator 1 Novo Nordisk AS $14.95 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811911885
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811911887
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811911889
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811911891
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811911893
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811911895
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811911897
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811911899
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811911901
Principal investigator 1 Novo Nordisk AS $650.00 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811911903
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811911905
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811911907
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811911909
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811911911
Principal investigator 1 Novo Nordisk AS $2.85 12/16/2021 Non-covered Recipient Entity
DHR INSTITUTE FOR RESEARCH AND DEVELOPMENT
EX6018-4758 No dispute reported 06/30/2026 811911913